Adaptimmune Therapeutics plc (MUN:473A)

Adaptimmune Therapeutics Statistics

Total Valuation

MUN:473A has a market cap or net worth of EUR 2.47 million. The enterprise value is 21.67 million.

Market Cap	2.47M
Enterprise Value	21.67M

Important Dates

The next estimated earnings date is Thursday, March 5, 2026.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+8.53%
Shares Change (QoQ)	+2.75%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	263.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.04
PB Ratio	-0.04
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.15
EV / Sales	0.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.13

Financial Position

The company has a current ratio of 1.52

Current Ratio	1.52
Quick Ratio	1.07
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.25
Interest Coverage	-26.10

Financial Efficiency

Return on equity (ROE) is -1,341.10% and return on invested capital (ROIC) is -152.32%.

Return on Equity (ROE)	-1,341.10%
Return on Assets (ROA)	-40.86%
Return on Invested Capital (ROIC)	-152.32%
Return on Capital Employed (ROCE)	-186.89%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	109,525
Profits Per Employee	-285,666
Employee Count	506
Asset Turnover	0.29
Inventory Turnover	20.28

Taxes

In the past 12 months, MUN:473A has paid 3.16 million in taxes.

Income Tax	3.16M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.76

Income Statement

In the last 12 months, MUN:473A had revenue of EUR 55.42 million and -144.55 million in losses. Loss per share was -0.56.

Revenue	55.42M
Gross Profit	-54.16M
Operating Income	-125.91M
Pretax Income	-141.39M
Net Income	-144.55M
EBITDA	-116.86M
EBIT	-125.91M
Loss Per Share	-0.56

Balance Sheet

The company has 22.19 million in cash and 41.45 million in debt, with a net cash position of -19.26 million.

Cash & Cash Equivalents	22.19M
Total Debt	41.45M
Net Cash	-19.26M
Net Cash Per Share	n/a
Equity (Book Value)	-60.42M
Book Value Per Share	-0.23
Working Capital	22.65M

Cash Flow

In the last 12 months, operating cash flow was -161.81 million and capital expenditures -1.40 million, giving a free cash flow of -163.20 million.

Operating Cash Flow	-161.81M
Capital Expenditures	-1.40M
Free Cash Flow	-163.20M
FCF Per Share	n/a

Margins

Gross margin is -97.73%, with operating and profit margins of -227.19% and -260.82%.

Gross Margin	-97.73%
Operating Margin	-227.19%
Pretax Margin	-255.12%
Profit Margin	-260.82%
EBITDA Margin	-210.86%
EBIT Margin	-227.19%
FCF Margin	n/a

Dividends & Yields

MUN:473A does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.53%
Shareholder Yield	-8.53%
Earnings Yield	-5,840.92%
FCF Yield	-6,594.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MUN:473A has an Altman Z-Score of -15.04. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.04
Piotroski F-Score	n/a